Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1983 2
1984 2
1987 3
1988 1
1989 2
1991 1
1992 1
1998 3
1999 1
2001 2
2004 1
2008 2
2009 2
2010 2
2011 2
2012 4
2013 2
2014 1
2015 2
2016 3
2017 2
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Vitamin D and multiple sclerosis.
Weinstock-Guttman B, Mehta BK, Ramanathan M, Karmon Y, Henson LJ, Halper J, Riskind P. Weinstock-Guttman B, et al. Among authors: riskind p. Neurologist. 2012 Jul;18(4):179-83. doi: 10.1097/NRL.0b013e31825bbf35. Neurologist. 2012. PMID: 22735240 Review.
The varieties of psychosis in multiple sclerosis: A systematic review of cases.
Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. Camara-Lemarroy CR, et al. Among authors: riskind p. Mult Scler Relat Disord. 2017 Feb;12:9-14. doi: 10.1016/j.msard.2016.12.012. Epub 2016 Dec 23. Mult Scler Relat Disord. 2017. PMID: 28283114
Why measure patient satisfaction?
Riskind P, Fossey L, Brill K. Riskind P, et al. J Med Pract Manage. 2011 Jan-Feb;26(4):217-20. J Med Pract Manage. 2011. PMID: 21506460
Relationships between multiple sclerosis and depression.
Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT. Byatt N, et al. Among authors: riskind p. J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):198-200. doi: 10.1176/jnp.23.2.jnp198. J Neuropsychiatry Clin Neurosci. 2011. PMID: 21677250
Branching enzyme deficiency: expanding the clinical spectrum.
Paradas C, Akman HO, Ionete C, Lau H, Riskind PN, Jones DE, Smith TW, Hirano M, Dimauro S. Paradas C, et al. Among authors: riskind pn. JAMA Neurol. 2014 Jan;71(1):41-7. doi: 10.1001/jamaneurol.2013.4888. JAMA Neurol. 2014. PMID: 24248152 Free PMC article.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
42 results